Collinson, P.O., Gaze, D.C., Bainbridge, K., Morris, F., Morris, B., Price, A. and Goodacre, S. (2006) Utility of admission cardiac troponin and “Ischemia Modified Albumin” measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department. Emergency Medicine Journal, 23, 256-261.

has been cited by the following article:

• TITLE: Cardio-Toxicity during chemotherapy: feasibility of new diagnostic approaches

  AUTHORS: Fable Zustovich, Mario Trivellato, Renato Ceravolo, Davide Pastorelli, Rosanna Canton, Lorena Buratin, Monica Mion, Martina Zaninotto, Martina Mattiazzi, Mario Plebani, Giuseppe Cartei

  KEYWORDS: Cardio-Toxicity Diagnostic

  JOURNAL NAME: Health, Vol.2 No.4, May 4, 2010

  ABSTRACT: Chemotherapy induced cardio-toxicity is a well known side effect of anticancer treatments, moreover the 70% of all tumors involve patients over 65 years-old, frequently with cardiac co- morbidity. We evaluated the feasibility of the application during chemotherapy administration of some of the most recent diagnostic techniques as 12-diagnostic leads telemetry, 7 days EKG monitoring device (R-Test Evolution 3R), blood level dosage of Brain Natriuretic Peptide (BNP) and Ischemia Modified Albumin (IMA). Some sub-clinical changes in the investigated parameters were found in patients undergoing chemotherapy, mostly containing fluorouracil, as shown in the following paper. Far from suggesting a widespread use of these methods during chemotherapy administration, we think that some more tools are needed to prevent cardiac toxicity in high-risk patients and some of what we studied may deserve further valuation in chemotherapy clinical trials.